Dermatology News

Topical tapinarof cream showed significant improvement of moderate to severe atopic dermatitis while being well tolerated by adults and children down to age 2 years, according to two phase 3 clinical trials.

An 8-year-old girl was seen for right-sided neck pain and an underlying lymph node measuring 2.5 cm with surrounding inflammatory swelling. What's your diagnosis?

Isotretinoin is associated with a clinically marginal increased risk for severe adverse events, leading researchers to advise routine blood testing commence shortly after initiation, according to a study.

The NIH has awarded Emma Guttman-Yassky, MD, PhD, a $6.6 million grant to investigate dupilumab as a treatment for children with alopecia areata, Mount Sinai announced in a press release.

Initiating infantile hemangioma treatment with propranolol 2 mg/kg per day did not yield more adverse events than 1 mg/kg per day, according to a study.

Ruxolitinib cream 1.5% was safe and well tolerated up for the short- and long-term treatment of atopic dermatitis in adolescents, according to an analysis of two phase 3 studies.

Acrochordons, also known as skin tags or fibroepithelial polyps, are correlated with metabolic disease and obesity in pediatric patients, according to a study.

Participation in the Pediatric Academic Societies Meeting is back to pre-COVID-19 levels of engagement, according to one of the event’s program chairs.

Stigma has a major impact on mental health and quality of life for pediatric patients with chronic skin diseases, according to a study.

The FDA has accepted Dermavant Science’s supplemental new drug application for Vtama cream 1% for the treatment of atopic dermatitis in adults and children aged 2 years and older, the company announced in a press release.